Skip to content
★ Sign in to follow
김

김성호

Executive
Insider activity · 24 months1 buy0 salesCumulative net flow
Total declarations
13
Companies
3
▲ Purchases (11 ops.)
€53k
▼ Sales (0 ops.)
—

Latest filing published 10 Aug 2026 for 진바이오텍.

Filing timeline

BuySale
김성호

Insider track record

Disclosed buys
11
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
11

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 14 Jul 2026 · 117 days ago
    +1.0%
    Entry ₩5,020 · Close 08 Oct 2026 ₩5,070
  • Filed 15 May 2026 · 177 days ago
    +15.8%
    Entry ₩4,060 · Close at T+90 ₩4,700
  • Filed 17 Apr 2026 · 205 days ago · €53k
    -14.0%
    Entry ₩213,500 · Close 08 Oct 2026 ₩183,600
  • Filed 08 Apr 2026 · 214 days ago
    -7.0%
    Entry ₩4,860 · Close at T+90 ₩4,520
  • Filed 01 Apr 2026 · 221 days ago
    -8.6%
    Entry ₩4,790 · Close at T+90 ₩4,380

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

김성호: trading record in brief

Filings by 김성호 span 3 companies, the busiest being 진바이오텍, NAVER Corporation and 이지스. In total, 13 filings cover trades dated from 12 April 2021 to 10 August 2026.

No open-market sale appears; the market trades are 11 purchases worth €53k. No amount is published for 10 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2026, the count stands at 8 purchases and no sales.

Of 11 purchases, 1 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

Most recently, on 10 August 2026, the filings show a transaction in 진바이오텍. The most recent open-market purchase was published on 14 July 2026, 117 days ago. Typically, a trade is published a median of 5 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. Source: insider filings from DART (FSS). Past trades are no guide to future returns.

Companies and markets linked to 김성호

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations13 total
  • Other(filed)
    0DART
  • ▲
    대량보유자Executives(filed)진바이오텍
    0DART
    99,212 sharesKRXDART:20260714000294
    Canonical exit: 12 Oct 2026 (T+90)
  • ▲
    Executives진바이오텍
    0DART
    86,941 sharesKRXDART:20260515000369
    Canonical exit: 10 Aug 2026 (T+90)
  • ▲
    리더ExecutivesNaver
    92M KRW37DART
    700 shares@ ₩131,000.000.0003% mcap100.0% of flowShareKRXDART:20260417000562
    Canonical exit: 9 Jul 2026 (T+90)
  • ▲
    Executives진바이오텍
    0DART
    92,434 sharesKRXDART:20260408002984
    Canonical exit: 25 Jun 2026 (T+90)
  • ▲
    Executives진바이오텍
    0DART
    92,086 sharesKRXDART:20260401000188
    Canonical exit: 24 Jun 2026 (T+90)
  • ▲
    Executives진바이오텍
    0DART
    87,787 sharesKRXDART:20260316000913
    Canonical exit: 10 Jun 2026 (T+90)
  • ●
    Executives이지스
    0DART
    0KRXDART:20260312000400
  • ▲
    Executives진바이오텍
    0DART
    87,418 sharesKRXDART:20260204000119
    Canonical exit: 5 May 2026 (T+90)
  • ▲
    Executives진바이오텍
    0DART
    90,411 sharesKRXDART:20260128000514
    Canonical exit: 23 Apr 2026 (T+90)
  • ▲
    대량보유자Executives진바이오텍
    0DART
    90,991 sharesKRXDART:20250704000038
    Canonical exit: 2 Oct 2025 (T+90)
  • ▲
    Executives(filed)진바이오텍
    0DART
    448,785 sharesKRXDART:20210712000405
    Canonical exit: 10 Oct 2021 (T+90)
  • ▲
    Executives(filed)진바이오텍
    0DART
    448,785 sharesKRXDART:20210412002385
    Canonical exit: 11 Jul 2021 (T+90)

13 of 13 declarations